BlackRock Fund Advisors’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$81M Buy
35,917
+5,224
+17% +$11.8M 0.01% 1361
2016
Q3
$76.9M Buy
30,693
+2,162
+8% +$5.42M 0.02% 1283
2016
Q2
$87.3M Buy
28,531
+598
+2% +$1.83M 0.02% 1082
2016
Q1
$88.7M Buy
27,933
+1,347
+5% +$4.28M 0.02% 1057
2015
Q4
$136M Buy
26,586
+287
+1% +$1.47M 0.03% 727
2015
Q3
$83.7M Buy
26,299
+1,080
+4% +$3.44M 0.02% 1043
2015
Q2
$101M Buy
25,219
+190
+0.8% +$760K 0.02% 988
2015
Q1
$100M Buy
25,029
+1,535
+7% +$6.13M 0.02% 1006
2014
Q4
$115M Buy
23,494
+1,823
+8% +$8.94M 0.03% 819
2014
Q3
$88.1M Sell
21,671
-432
-2% -$1.76M 0.02% 939
2014
Q2
$89.4M Sell
22,103
-1,187
-5% -$4.8M 0.03% 964
2014
Q1
$106M Buy
23,290
+521
+2% +$2.37M 0.03% 802
2013
Q4
$79.8M Buy
22,769
+785
+4% +$2.75M 0.02% 1022
2013
Q3
$90.2M Buy
21,984
+2,683
+14% +$11M 0.03% 839
2013
Q2
$76.4M Buy
+19,301
New +$76.4M 0.03% 852